Streetbeat News

Stock Prices

LAZR

Goldman Sachs analyst Mark Delaney has reiterated a Sell rating on Luminar Technologies (NASDAQ:LAZR) and reduced the price target from $3 to $2.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:12 pm

LRCX

Goldman Sachs analyst Toshiya Hari has reaffirmed a Buy rating on Lam Research (NASDAQ:LRCX) and increased the price target from $700 to $912, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:12 pm

INO

Oppenheimer analyst Hartaj Singh has upgraded Inovio Pharmaceuticals (NASDAQ:INO) from Perform to Outperform and set a price target of $4. This upgrade reflects a positive outlook on the company's stock by the analyst.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:12 pm

AAL

An executive from American Airlines mentioned during a conference call that the company is experiencing bookings for summer long-haul flights on a revenue basis at the same rates as last year, which was notably strong.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:10 pm

CFR

Cullen/Frost Bankers (NYSE:CFR) reported Q4 earnings with an EPS of $2.18, beating estimates by 7.39% but with a revenue decline of $2.23 million from the previous year. Despite beating EPS estimates last quarter, the share price dropped by 2.63% the following day. Historical earnings data shows fluctuating performance over the past four quarters.

Portfolio Pulse from Benzinga Insights

January 25, 2024 | 2:10 pm

TAL

JP Morgan analyst DS Kim has upgraded TAL Education (NYSE:TAL) from Neutral to Overweight and set a price target of $15.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:09 pm

GOVT

SCHO

SCHR

The U.S. Treasury is expected to announce an increase in government bond supply on Jan. 31, raising questions about whether investor demand can keep pace. Demand for Treasuries dropped in late 2023, with yields peaking in October. However, demand has returned as the Fed's rate hike cycle appears to have peaked, and expectations of rate cuts have grown. Bank of America's Mark Cabana anticipates the Treasury will repeat the auction size increases seen in November. ETFs like iShares U.S. Treasury Bond ETF (GOVT), Schwab Short-Term U.S. Treasury ETF (SCHO), and Schwab Intermediate-Term U.S. Treasury ETF (SCHR) allow investors to track bond price movements. Despite concerns, auction performance has not consistently deteriorated, and a range of investors has shown improved demand for Treasuries.

Portfolio Pulse from Neil Dennis

January 25, 2024 | 2:09 pm

IDYA

Goldman Sachs analyst Corinne Jenkins has reaffirmed a Buy rating on IDEAYA Biosciences (NASDAQ:IDYA) and increased the price target from $36 to $53, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:09 pm

AKTS

Akoustis Technologies has priced a public offering of 20 million shares at $0.50 per share. This offering represents a significant increase in the company's outstanding shares and could potentially dilute the value of existing shares.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:09 pm

OTLK

Guggenheim analyst Eddie Hickman has upgraded Outlook Therapeutics (NASDAQ:OTLK) from Neutral to Buy and set a price target of $2. This upgrade reflects a positive change in the analyst's view of the company's stock potential.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:07 pm